| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/18/1998 | WO1998025959A2 Secreted human proteins |
| 06/18/1998 | WO1998025958A2 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the tnf ligand family |
| 06/18/1998 | WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/18/1998 | WO1998018919A3 GABAa Receptor subunit epsilon-related protein |
| 06/18/1998 | DE19727815C1 Monoclonal antibody specific for CD164 |
| 06/18/1998 | DE19727813C1 Monoclonal antibody specific for CD164 |
| 06/18/1998 | CA2274986A1 Reading frame independent epitope tagging |
| 06/18/1998 | CA2274801A1 Mammalian cell surface antigens; related reagents |
| 06/18/1998 | CA2274515A1 Glutathionylspermidine synthetase |
| 06/18/1998 | CA2274500A1 Bone stimulating factor |
| 06/18/1998 | CA2274493A1 Method for altering the nutritional content of plant seed |
| 06/18/1998 | CA2274490A1 Non-m non-o hiv strains, fragments and applications |
| 06/18/1998 | CA2274311A1 Streptococcus pneumoniae dna sequences |
| 06/18/1998 | CA2272822A1 Hvem polypeptides and uses thereof |
| 06/18/1998 | CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/17/1998 | EP0848064A1 New antibiotic, Feglymycine, process for its preparation and use of the same |
| 06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
| 06/17/1998 | EP0848060A2 Novel human 11CB splice variant |
| 06/17/1998 | EP0848013A1 NM03, a monoclonal antibody to HIV-1 gp120 protein |
| 06/17/1998 | EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 06/17/1998 | EP0847398A1 Colon specific genes and proteins |
| 06/17/1998 | EP0745124B1 Mammalian cell cycle protein |
| 06/17/1998 | EP0611376B1 Production and use of multimeric hemoglobins |
| 06/17/1998 | EP0575452B1 Method for production of a vegetable protein hydrolyzate |
| 06/17/1998 | EP0569537B1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 06/17/1998 | EP0448704B1 Osteogenic devices |
| 06/17/1998 | EP0254735B2 METHOD FOR PRODUCTION OF THERMALLY STABLE AND pH STABLE SUBTILISIN ANALOGS |
| 06/17/1998 | CN1185180A Gene expression in mammalian cells |
| 06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
| 06/17/1998 | CN1185159A 人血管内皮生长因子3 Human vascular endothelial growth factor 3 |
| 06/17/1998 | CA2205712A1 Process for converting waste protein sources into a balanced animal feed |
| 06/16/1998 | US5767364 Endo-1,4-beta-D-glucanase |
| 06/16/1998 | US5767363 Recombinant dna construct |
| 06/16/1998 | US5767260 A nucleic acid coding for two epitope-containing polypeptide joined by a peptide linker and attached to phospholipase a activating protein or tumor necrosis factor; antiinflammatory agents |
| 06/16/1998 | US5767251 Polypeptides |
| 06/16/1998 | US5767250 Complexes comprising truncated CMV gH polypeptides and escort proteins |
| 06/16/1998 | US5767248 Alzheimers |
| 06/16/1998 | US5767247 Anti-annexin-V monoclonal antibodies, and preparation and use thereof |
| 06/16/1998 | US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 06/16/1998 | US5767243 A complex of human afamin and apolipoprotein a1; a monoclonal antibody specific for human afamin |
| 06/16/1998 | US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 06/16/1998 | US5767241 Soluble form of GMP-140 |
| 06/16/1998 | US5767240 Activity-dependent neurotrophic factor |
| 06/16/1998 | US5767069 Cyclosporins |
| 06/16/1998 | US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same |
| 06/16/1998 | US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4 |
| 06/16/1998 | US5766948 Culturing neuroblast cells in vessel in serum-free basal medium supplemented with basic fibroblast growth factor, wherein surface of vessel allows attachment of cells |
| 06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
| 06/16/1998 | US5766946 Monoclonal antibodies to glycoprotein P |
| 06/16/1998 | US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine |
| 06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
| 06/16/1998 | US5766914 Method of producing and purifying enzymes |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766877 Genes encoding art, an agouti-related transcript |
| 06/16/1998 | US5766874 Kit containing d-arabinitol dehydrogenase and NAD+ for determining d-arabinitol |
| 06/16/1998 | US5766863 Kinase receptor activation assay |
| 06/16/1998 | US5766850 Human β2 integrin α subunit |
| 06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
| 06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
| 06/16/1998 | US5766840 Purified antibody preparation |
| 06/16/1998 | US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine |
| 06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
| 06/16/1998 | US5766599 Attenuated virus; genetic engineering |
| 06/16/1998 | US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell |
| 06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
| 06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
| 06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
| 06/16/1998 | US5765538 Pump device for a fuel vapor retention system of an internal combustion engine |
| 06/13/1998 | CA2224025A1 Novel antibiotic, feglymycin, processes for its preparation and its use |
| 06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents |
| 06/11/1998 | WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein |
| 06/11/1998 | WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 06/11/1998 | WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/11/1998 | WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/11/1998 | WO1998024819A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 06/11/1998 | WO1998024817A1 Novel dna, novel protein, and novel antibody |
| 06/11/1998 | WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 06/11/1998 | WO1998012910A3 Novel CREBa isoform |
| 06/11/1998 | WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 06/11/1998 | CA2722378A1 Human antibodies that bind tnf alpha |
| 06/11/1998 | CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury |
| 06/11/1998 | CA2274309A1 Novel dna, novel protein, and novel antibody |
| 06/11/1998 | CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/11/1998 | CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 06/11/1998 | CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | CA2224334A1 Self-enhancing, pharmacologically controllable expression systems |
| 06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
| 06/10/1998 | EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family |
| 06/10/1998 | EP0846763A2 A protein phosphatase 1 binding protein, R5 |